Numinus

About

Numinus is a publicly traded psychedelic therapy organization headquartered in Vancouver, British Columbia, with clinical locations across Canada and the United States including sites in Utah, Illinois, Massachusetts, and California. The organization holds the distinction of being one of the first in Canada to receive Health Canada approval for psilocybin-assisted therapy and continues to facilitate access to psilocybin and MDMA-assisted therapies through the federal Special Access Program. All practitioners are registered clinical counselors or registered social workers trained in trauma-informed approaches, combining established therapeutic modalities such as CBT and EMDR with somatic, mindfulness-based, and psychedelic integration therapies. The five-step treatment model — Connect, Prepare, Experience, Integrate, and Reconnect — provides a structured therapeutic container that extends well beyond the pharmacological action of the medicine. Numinus also conducts clinical research and training, contributing to the evidence base for psychedelic-assisted therapies and the professional development of the field.

Depth Orientation

Numinus operates at the intersection of evidence-based psychotherapy and psychedelic medicine, employing registered clinical counselors and registered social workers who combine established modalities like EMDR with emerging somatic and mindfulness-based therapies. As one of the first organizations to receive Health Canada approval for psilocybin-assisted therapy and to participate in MDMA clinical access programs, the center brings institutional credibility to a therapeutically grounded psychedelic model. Their trauma-informed approach treats psychedelic experiences as catalysts for deeper psychological work rather than standalone interventions.

Treatment Modalities

Program Details

Best for

• Treatment-resistant depression
• PTSD
• Anxiety
• Addiction
• Eating disorders
• Chronic pain

Contact